2018-2023 Global Oncolytic Virus Therapy Market Report (Status and Outlook)

July 2018 | 131 pages | ID: 2DAE792265BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Oncolytic Virus Therapy market for 2018-2023.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The application of oncolytic virus therapy includes melanoma, prostate cancer, breast cancer, ovarian cancer and others, and the proportion of R&D Investment for melanoma in 2017 is about 34%.
Market competition is intense. Amgen, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry.
Over the next five years, LPI(LP Information) projects that Oncolytic Virus Therapy will register a 25.8% CAGR in terms of revenue, reach US$ 10 million by 2023, from US$ 2 million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Oncolytic Virus Therapy market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• HSV-based Oncolytic Viruses
• Adenoviruses-based Oncolytic Viruses
• Vesicular Stomatitis Virus-based Oncolytic Viruses
• Newcastle Disease Virus-based Oncolytic Viruses

Segmentation by application:

• Melanoma
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer 
• Others

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Amgen
• Oncolytics Biotech
• Viralytics
• Transgene SA
• Oncolys BioPharma
• Targovax
• PsiOxus Therapeutics
• SillaJen Biotherapeutics
• Sorrento Therapeutics
• Lokon Pharma
• Genelux Corporation
• Vyriad
• TILT Biotherapeutics
• Cold Genesys

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Oncolytic Virus Therapy market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Oncolytic Virus Therapy market by identifying its various subsegments.
• Focuses on the key global Oncolytic Virus Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Oncolytic Virus Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Oncolytic Virus Therapy submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oncolytic Virus Therapy Market Size 2013-2023
  2.1.2 Oncolytic Virus Therapy Market Size CAGR by Region
2.2 Oncolytic Virus Therapy Segment by Type
  2.2.1 HSV-based Oncolytic Viruses
  2.2.2 Adenoviruses-based Oncolytic Viruses
  2.2.3 Vaccinia Virus-based Oncolytic Viruses
  2.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
  2.2.5 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy Market Size by Type
  2.3.1 Global Oncolytic Virus Therapy Market Size Market Share by Type (2013-2018)
  2.3.2 Global Oncolytic Virus Therapy Market Size Growth Rate by Type (2013-2018)
2.4 Oncolytic Virus Therapy Segment by Application
  2.4.1 Melanoma
  2.4.2 Prostate Cancer
  2.4.3 Breast Cancer
  2.4.4 Ovarian Cancer
  2.4.5 Others
2.5 Oncolytic Virus Therapy Market Size by Application
  2.5.1 Global Oncolytic Virus Therapy Market Size Market Share by Application (2013-2018)
  2.5.2 Global Oncolytic Virus Therapy Market Size Growth Rate by Application (2013-2018)

3 GLOBAL ONCOLYTIC VIRUS THERAPY BY PLAYERS

3.1 Global Oncolytic Virus Therapy Market Size Market Share by Players
  3.1.1 Global Oncolytic Virus Therapy Market Size by Players (2016-2018)
  3.1.2 Global Oncolytic Virus Therapy Market Size Market Share by Players (2016-2018)
3.2 Global Oncolytic Virus Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ONCOLYTIC VIRUS THERAPY BY REGIONS

4.1 Oncolytic Virus Therapy Market Size by Regions
4.2 Americas Oncolytic Virus Therapy Market Size Growth
4.3 APAC Oncolytic Virus Therapy Market Size Growth
4.4 Europe Oncolytic Virus Therapy Market Size Growth
4.5 Middle East & Africa Oncolytic Virus Therapy Market Size Growth

5 AMERICAS

5.1 Americas Oncolytic Virus Therapy Market Size by Countries
5.2 Americas Oncolytic Virus Therapy Market Size by Type
5.3 Americas Oncolytic Virus Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Oncolytic Virus Therapy Market Size by Countries
6.2 APAC Oncolytic Virus Therapy Market Size by Type
6.3 APAC Oncolytic Virus Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Oncolytic Virus Therapy by Countries
7.2 Europe Oncolytic Virus Therapy Market Size by Type
7.3 Europe Oncolytic Virus Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oncolytic Virus Therapy by Countries
8.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type
8.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET FORECAST

10.1 Global Oncolytic Virus Therapy Market Size Forecast (2018-2023)
10.2 Global Oncolytic Virus Therapy Forecast by Regions
  10.2.1 Global Oncolytic Virus Therapy Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Oncolytic Virus Therapy Forecast by Type
10.8 Global Oncolytic Virus Therapy Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Amgen
  11.1.1 Company Details
  11.1.2 Oncolytic Virus Therapy Product Offered
  11.1.3 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Amgen News
11.2 Oncolytics Biotech
  11.2.1 Company Details
  11.2.2 Oncolytic Virus Therapy Product Offered
  11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Oncolytics Biotech News
11.3 Viralytics
  11.3.1 Company Details
  11.3.2 Oncolytic Virus Therapy Product Offered
  11.3.3 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Viralytics News
11.4 Transgene SA
  11.4.1 Company Details
  11.4.2 Oncolytic Virus Therapy Product Offered
  11.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Transgene SA News
11.5 Oncolys BioPharma
  11.5.1 Company Details
  11.5.2 Oncolytic Virus Therapy Product Offered
  11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Oncolys BioPharma News
11.6 Targovax
  11.6.1 Company Details
  11.6.2 Oncolytic Virus Therapy Product Offered
  11.6.3 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Targovax News
11.7 PsiOxus Therapeutics
  11.7.1 Company Details
  11.7.2 Oncolytic Virus Therapy Product Offered
  11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 PsiOxus Therapeutics News
11.8 SillaJen Biotherapeutics
  11.8.1 Company Details
  11.8.2 Oncolytic Virus Therapy Product Offered
  11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 SillaJen Biotherapeutics News
11.9 Sorrento Therapeutics
  11.9.1 Company Details
  11.9.2 Oncolytic Virus Therapy Product Offered
  11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Sorrento Therapeutics News
11.10 Lokon Pharma
  11.10.1 Company Details
  11.10.2 Oncolytic Virus Therapy Product Offered
  11.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Lokon Pharma News
11.11 Genelux Corporation
11.12 Vyriad
11.13 TILT Biotherapeutics
11.14 Cold Genesys

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Oncolytic Virus Therapy
Figure Oncolytic Virus Therapy Report Years Considered
Figure Market Research Methodology
Figure Global Oncolytic Virus Therapy Market Size Growth Rate 2013-2023 ($ Millions)
Table Oncolytic Virus Therapy Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of HSV-based Oncolytic Viruses
Table Major Players of Adenoviruses-based Oncolytic Viruses
Table Major Players of Vaccinia Virus-based Oncolytic Viruses
Table Major Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table Major Players of Newcastle Disease Virus-based Oncolytic Viruses
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Market Share by Type (2013-2018)
Figure Global Oncolytic Virus Therapy Market Size Market Share by Type (2013-2018)
Figure Global HSV-based Oncolytic Viruses Market Size Growth Rate
Figure Global Adenoviruses-based Oncolytic Viruses Market Size Growth Rate
Figure Global Vaccinia Virus-based Oncolytic Viruses Market Size Growth Rate
Figure Global Vesicular Stomatitis Virus-based Oncolytic Viruses Market Size Growth Rate
Figure Global Newcastle Disease Virus-based Oncolytic Viruses Market Size Growth Rate
Figure Oncolytic Virus Therapy Consumed in Melanoma
Figure Global Oncolytic Virus Therapy Market: Melanoma (2013-2018) ($ Millions)
Figure Global Melanoma YoY Growth ($ Millions)
Figure Oncolytic Virus Therapy Consumed in Prostate Cancer
Figure Global Oncolytic Virus Therapy Market: Prostate Cancer (2013-2018) ($ Millions)
Figure Global Prostate Cancer YoY Growth ($ Millions)
Figure Oncolytic Virus Therapy Consumed in Breast Cancer
Figure Global Oncolytic Virus Therapy Market: Breast Cancer (2013-2018) ($ Millions)
Figure Global Breast Cancer YoY Growth ($ Millions)
Figure Oncolytic Virus Therapy Consumed in Ovarian Cancer
Figure Global Oncolytic Virus Therapy Market: Ovarian Cancer (2013-2018) ($ Millions)
Figure Global Ovarian Cancer YoY Growth ($ Millions)
Figure Oncolytic Virus Therapy Consumed in Others
Figure Global Oncolytic Virus Therapy Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Oncolytic Virus Therapy Market Size by Application (2013-2018) ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Market Share by Application (2013-2018)
Figure Global Oncolytic Virus Therapy Market Size Market Share by Application (2013-2018)
Figure Global Oncolytic Virus Therapy Market Size in Melanoma Growth Rate
Figure Global Oncolytic Virus Therapy Market Size in Prostate Cancer Growth Rate
Figure Global Oncolytic Virus Therapy Market Size in Breast Cancer Growth Rate
Figure Global Oncolytic Virus Therapy Market Size in Ovarian Cancer Growth Rate
Figure Global Oncolytic Virus Therapy Market Size in Others Growth Rate
Table Global Oncolytic Virus Therapy Revenue by Players (2016-2018) ($ Millions)
Table Global Oncolytic Virus Therapy Revenue Market Share by Players (2016-2018)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Players in 2017
Table Global Oncolytic Virus Therapy Key Players Head office and Products Offered
Table Oncolytic Virus Therapy Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Oncolytic Virus Therapy Market Size by Regions 2013-2018 ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Market Share by Regions 2013-2018
Figure Global Oncolytic Virus Therapy Market Size Market Share by Regions 2013-2018
Figure Americas Oncolytic Virus Therapy Market Size 2013-2018 ($ Millions)
Figure APAC Oncolytic Virus Therapy Market Size 2013-2018 ($ Millions)
Figure Europe Oncolytic Virus Therapy Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Oncolytic Virus Therapy Market Size 2013-2018 ($ Millions)
Table Americas Oncolytic Virus Therapy Market Size by Countries (2013-2018) ($ Millions)
Table Americas Oncolytic Virus Therapy Market Size Market Share by Countries (2013-2018)
Figure Americas Oncolytic Virus Therapy Market Size Market Share by Countries in 2017
Table Americas Oncolytic Virus Therapy Market Size by Type (2013-2018) ($ Millions)
Table Americas Oncolytic Virus Therapy Market Size Market Share by Type (2013-2018)
Figure Americas Oncolytic Virus Therapy Market Size Market Share by Type in 2017
Table Americas Oncolytic Virus Therapy Market Size by Application (2013-2018) ($ Millions)
Table Americas Oncolytic Virus Therapy Market Size Market Share by Application (2013-2018)
Figure Americas Oncolytic Virus Therapy Market Size Market Share by Application in 2017
Figure United States Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Canada Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Table APAC Oncolytic Virus Therapy Market Size by Countries (2013-2018) ($ Millions)
Table APAC Oncolytic Virus Therapy Market Size Market Share by Countries (2013-2018)
Figure APAC Oncolytic Virus Therapy Market Size Market Share by Countries in 2017
Table APAC Oncolytic Virus Therapy Market Size by Type (2013-2018) ($ Millions)
Table APAC Oncolytic Virus Therapy Market Size Market Share by Type (2013-2018)
Figure APAC Oncolytic Virus Therapy Market Size Market Share by Type in 2017
Table APAC Oncolytic Virus Therapy Market Size by Application (2013-2018) ($ Millions)
Table APAC Oncolytic Virus Therapy Market Size Market Share by Application (2013-2018)
Figure APAC Oncolytic Virus Therapy Market Size Market Share by Application in 2017
Figure China Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Japan Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Korea Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure India Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Australia Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Table Europe Oncolytic Virus Therapy Market Size by Countries (2013-2018) ($ Millions)
Table Europe Oncolytic Virus Therapy Market Size Market Share by Countries (2013-2018)
Figure Europe Oncolytic Virus Therapy Market Size Market Share by Countries in 2017
Table Europe Oncolytic Virus Therapy Market Size by Type (2013-2018) ($ Millions)
Table Europe Oncolytic Virus Therapy Market Size Market Share by Type (2013-2018)
Figure Europe Oncolytic Virus Therapy Market Size Market Share by Type in 2017
Table Europe Oncolytic Virus Therapy Market Size by Application (2013-2018) ($ Millions)
Table Europe Oncolytic Virus Therapy Market Size Market Share by Application (2013-2018)
Figure Europe Oncolytic Virus Therapy Market Size Market Share by Application in 2017
Figure Germany Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure France Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure UK Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Italy Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Russia Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Spain Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Oncolytic Virus Therapy Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Countries in 2017
Table Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Type in 2017
Table Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Application in 2017
Figure Egypt Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Israel Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Oncolytic Virus Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Global Oncolytic Virus Therapy arket Size Forecast (2018-2023) ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Market Share Forecast by Regions
Figure Americas Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure APAC Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Europe Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure United States Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Canada Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Mexico Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Brazil Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure China Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Japan Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Korea Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure India Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Australia Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Germany Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure France Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure UK Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Italy Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Russia Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Spain Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Egypt Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure South Africa Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Israel Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure Turkey Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Figure GCC Countries Oncolytic Virus Therapy Market Size 2018-2023 ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Market Share Forecast by Type (2018-2023)
Table Global Oncolytic Virus Therapy Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Oncolytic Virus Therapy Market Size Market Share Forecast by Application (2018-2023)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Amgen Oncolytic Virus Therapy Market Share (2016-2018)
Table Oncolytics Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oncolytics Biotech Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Oncolytics Biotech Oncolytic Virus Therapy Market Share (2016-2018)
Table Viralytics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Viralytics Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Viralytics Oncolytic Virus Therapy Market Share (2016-2018)
Table Transgene SA Basic Information, Head Office, Major Market Areas and Its Competitors
Table Transgene SA Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Transgene SA Oncolytic Virus Therapy Market Share (2016-2018)
Table Oncolys BioPharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oncolys BioPharma Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Oncolys BioPharma Oncolytic Virus Therapy Market Share (2016-2018)
Table Targovax Basic Information, Head Office, Major Market Areas and Its Competitors
Table Targovax Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Targovax Oncolytic Virus Therapy Market Share (2016-2018)
Table PsiOxus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table PsiOxus Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure PsiOxus Therapeutics Oncolytic Virus Therapy Market Share (2016-2018)
Table SillaJen Biotherapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure SillaJen Biotherapeutics Oncolytic Virus Therapy Market Share (2016-2018)
Table Sorrento Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sorrento Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Sorrento Therapeutics Oncolytic Virus Therapy Market Share (2016-2018)
Table Lokon Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Lokon Pharma Oncolytic Virus Therapy Revenue and Gross Margin (2016-2018)
Figure Lokon Pharma Oncolytic Virus Therapy Market Share (2016-2018)
Table Genelux Corporation Basic Information, Head Office, Major Market Areas and Its Competitors
Table Vyriad Basic Information, Head Office, Major Market Areas and Its Competitors
Table TILT Biotherapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cold Genesys Basic Information, Head Office, Major Market Areas and Its Competitors